financetom
Business
financetom
/
Business
/
Chili's Parent Brinker Fiscal 2025 EPS Guidance Misses Views at Midpoint; Shares Slump
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Chili's Parent Brinker Fiscal 2025 EPS Guidance Misses Views at Midpoint; Shares Slump
Aug 14, 2024 11:16 AM

01:53 PM EDT, 08/14/2024 (MT Newswires) -- Brinker International ( EAT ) on Wednesday outlined a fiscal 2025 earnings outlook range that missed Wall Street's estimates at the midpoint after its fourth-quarter bottom-line didn't rise as much as expected, sending the casual dining restaurant company's shares tumbling.

The company, which owns the Chili's Grill & Bar ( EAT ) chain, expects 2025 adjusted earnings between $4.35 and $4.75 per share on revenue of $4.55 billion to $4.62 billion. Analysts polled by Capital IQ are looking for normalized EPS of $4.70 on revenue of $4.56 billion.

Adjusted EPS rose to $1.61 for the quarter through June 26 from $1.39 a year earlier, but missed the Street's $1.72 estimate. Revenue increased to $1.21 billion from $1.08 billion, topping the $1.16 billion modeled by analysts.

Brinker ( EAT ) shares were down 11% in Wednesday afternoon trade.

Fourth-quarter company-level comparable restaurant sales jumped almost 14%, blowing past the Street's 8.6% growth view. The company said Chili's ( EAT ) comparable sales surged nearly 15% amid increased menu pricing and higher traffic. Chili's ( EAT ) traffic grew 5.9%, but included a roughly 2.3% hit from Brinker's ( EAT ) "strategic decision to de-emphasize virtual brands," according to a statement. Maggiano's Little Italy ( EAT ) comparable sales rose 2.5%.

"We achieved another quarter of solid progress against our strategy to deliver profitable, sustainable growth," Chief Executive Kevin Hochman said. "We significantly outperformed the industry in both sales and traffic during the quarter, while maintaining record high guest metrics."

The company said its investment in the business resulted in increased restaurant staffing and repairs and maintenance expense during the quarter.

Fiscal 2024 adjusted EPS jumped to $4.10 from $2.83 a year earlier, but lagged the Street's $4.22 view. Revenue rose to $4.42 billion from $4.13 billion, surpassing analysts' $4.37 billion consensus view. Company-level comparable restaurant sales grew 7%.

Price: 62.09, Change: -8.32, Percent Change: -11.81

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Triple Flag To Acquire A Royalty On Tres Quebradas
BRIEF-Triple Flag To Acquire A Royalty On Tres Quebradas
Dec 19, 2024
Dec 19 (Reuters) - Triple Flag Precious Metals Corp ( TFPM ) : * TRIPLE FLAG TO ACQUIRE A ROYALTY ON TRES QUEBRADAS * TRIPLE FLAG PRECIOUS METALS CORP ( TFPM ): PROPOSED DEAL FOR US$28 MILLION * TRIPLE FLAG PRECIOUS METALS CORP ( TFPM ): A 0.5% GOR ROYALTY COVERS ALL MINERAL PROPERTIES COMPRISING TRES QUEBRADAS LITHIUM PROJECT Source...
Vermilion Hikes Dividend, Announces 2025 Guidance; Shares Slightly Up in U.S. Pre-Market
Vermilion Hikes Dividend, Announces 2025 Guidance; Shares Slightly Up in U.S. Pre-Market
Dec 19, 2024
07:47 AM EST, 12/19/2024 (MT Newswires) -- Vermilion Energy ( VET ) 's share price inched up 0.7% at last look Thursday on the NYSE pre-market trading as it announced an 8% increase in dividend to $0.13 per share, effective in the first quarter of 2025. The dividend is payable April 15. The base dividend will amount to approximately $80...
Market Chatter: Novartis to Close MorphoSys Sites, Affecting 330 Jobs
Market Chatter: Novartis to Close MorphoSys Sites, Affecting 330 Jobs
Dec 19, 2024
07:47 AM EST, 12/19/2024 (MT Newswires) -- Novartis ( NVS ) will wind down MorphoSys sites in Germany and the US, affecting about 330 jobs, Reuters reported Thursday, citing the company. The report said the decision follows Novartis' ( NVS ) acquisition of MorphoSys earlier this year and is part of an ongoing evaluation of its organizational structure and research...
Top Premarket Decliners
Top Premarket Decliners
Dec 19, 2024
07:45 AM EST, 12/19/2024 (MT Newswires) -- Lamb Weston Holdings ( LW ) shares were down 18% pre-bell Thursday after the company reported lower fiscal Q2 adjusted earnings and revenue in addition to trimming its fiscal 2025 outlook. Quantum Biopharma ( QNTM ) stock was 17% lower, extending Wednesday's slide. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved